Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics), By Phase (Phase I, II, III), By Region (APAC, North America), And Segment Forecasts, 2023 - 2032

The global clinical trial equipment & ancillary solutions market size was valued at USD 2.7 billion in 2022 and is anticipated to exhibit a compound annual growth rate (CAGR) of 8.1% from 2023 to 2032.

Clinical Trial Equipment & Ancillary Solutions Market Size 2023 To 2032

Key Pointers

  • The supply/logistics segment dominated the market and accounted for the largest revenue share of 38.8% in 2022.
  • The sourcing segment on the other hand is anticipated to witness a considerable growth rate of 7.9% across the forecast period.
  • The phase III segment accounted for the maximum revenue share of the global market of 54.1% in 2022.
  • North America dominated the global clinical trial equipment & ancillary solutions market in 2022 with the largest revenue share of 40.4%. 
  • Asia Pacific is projected to be the fastest-growing regional market with a CAGR of 9.5% during the forecast period.

Report Scope of The Clinical Trial Equipment & Ancillary Solutions Market:

                Report Coverage                 Details
Market Size In 2022 USD 2.7 Billion
Revenue Forecast By 2032 USD 5.88 Billion
Growth Rate From 2023 to 2032 8.1%
Base Year 2022
Forecast Period 2023-2032
Segments Covered Product, Phase
Market Analysis (Terms Used) Revenue In USD Million/Billion And CAGR From 2023 To 2032
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Key Companies Profiled Ancillare LP; Imperial CRS; Woodley Equipment Company Ltd.; Thermo Fisher Scientific, Inc.; PAREXEL International Corp.; Emsere (Medicapital Rent); Quipment SAS; IRM; Marken A UPS Company; Myonex; Yourway

 

The global market has noticed critical growth on account of the rising R&D investments, evolving need for clinical trials, and the rapid growth of the pharmaceutical and medical industries. The COVID-19 outbreak temporarily slowed down the process of clinical trials in 2020, owing to the national lockdown implemented by the government, which had affected the market negatively. However, the growing demand for an effective treatment for COVID-19 and other diseases improves the number of trials post covid. For instance, according to ClinicalTrial.Gov, 325,761 studies were reported in 2020, whereas in 2022 the number of studies reached 399502 by 2023. The surge in clinical studies is expected to support the market post-pandemic.

As clinical trials evolve, more resources are required for a clinical trial, including the drugs, equipment, and ancillary supplies. Ancillary supplies include all items necessary to perform a clinical study, such as syringes, surgical knives, swabs, gloves, and any other material that the patient and medical professional need to administer the medication and analyze the effectiveness and safety parameters under examination.

Sourcing equipment & ancillary materials for clinical trials involves considerably more than just procurement. It needs an in-depth understanding of the study’s design and requirements, as well as rigorous proactive planning to guarantee that the most relevant equipment and supplies are bought at the correct time and at a reasonable price. A combination of internal knowledge and external help is strongly recommended in handling the complexity of equipment and ancillary supply, restocking, logistics, and expiry management.

There is a massive rise in the number of clinical studies being undertaken for COVID-19, and this is expected to improve market growth. Apart from this high investment in R&D and adoption of virtual clinical trials owing to the pandemic have further supported the market growth.

Clinical Trial Equipment & Ancillary Solutions Market Report Segmentation:

Product

  • Sourcing
    • Procurement
      • Equipment
      • Ancillaries
    • Rental
      • Equipment
      • Ancillaries
  • Supply/Logistics
    • Transportation
    • Packaging
    • Others
  • Service
    • Calibrations
    • Equipment Servicing
    • Others
  • Others

Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Frequently Asked Questions

The global clinical trial equipment & ancillary solutions market size was valued at USD 2.7 billion in 2022 and is predicted to reach around USD 5.88 billion by 2032.

The global clinical trial equipment & ancillary solutions market is poised to grow at a CAGR of 8.1% from 2023 to 2032.

The key players operating in the clinical trial equipment & ancillary solutions market are Ancillare LP; Imperial CRS; Woodley Equipment Company Ltd.; Thermo Fisher Scientific, Inc.; PAREXEL International Corp.; Emsere (Medicapital Rent); Quipment SAS; IRM; Marken A UPS Company; Myonex; Yourway

Report Detail

  • Report Code:119980
  • No. of Pages:150+
  • Format:PDF/PPT/Excel

Proceed To Buy

USD 1599
USD 2999

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers